Latin American Acquisition, Creation of i3 in India Are Latest Key Components
BASKIN RIDGE, NJ, December 7, 2006— Pharmaceutical services company i3 today announced the next phase of its global expansion, which includes organic and acquired growth in India, Latin America, and Eastern and Western Europe. Coupled with important acquisitions earlier this year in Canada and Asia/Pacific, these additions to the i3 family will help i3’s pharmaceutical clients bring high-quality, well-tested drugs to market faster and more affordably by augmenting i3’s ability to provide customers access to a large pool of patients and investigators and the most efficient services from across the globe. They will further enhance i3’s position as a leading specialized pharmaceutical services organization in the world.
“Our strategy of increased geographic reach continues to honor i3’s responsibility to our customers,” said Glenn Bilawsky, CEO of i3. “Pharmaceutical companies want to expedite development and gain cost efficiencies through well-run trials that are completed on time and on budget. Our expansion will help us accomplish those goals while still maintaining i3’s commitment to specialization and quality, which has become an industry hallmark.”
i3 Operations in Latin America
i3 announced today its acquisition of one of Latin America’s largest privately held contract research organizations (CRO), with operations in Argentina, Brazil, Costa Rica, Mexico, Peru and Uruguay. This full service CRO specializes in clinical research and professional outsourcing and has a wide range of medium to large pharmaceutical and biotechnology clients. Its emphasis on quality dovetails nicely with i3’s six-sigma approach to process improvement that builds in quality at all levels. i3 intends to operate the new organization as i3 Latin America.
“The Latin American market is 500 million people strong and the pharmaceutical industry’s demand for CRO-related services is growing rapidly there,” said Nigel Page, president of i3 Research. “i3 Latin America will extend i3’s capabilities for our customers with known and emerging needs in Latin America and brings i3’s regional strength, expertise and investment to this critical market.”
i3 Operations in India
i3 also is expanding into India with a full-service office in Delhi. In India, i3 will provide clinical research and data services offerings for India-specific and global trials. In addition to project management, monitoring, regulatory and quality assurance services, its data services offerings will include data entry and programming, data management, biostatistics and statistical programming. A staffing solutions business will meet the temporary staffing needs of pharmaceutical companies in India a |
.gif){kind=small}